Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
A Phase I Trial Evaluating the Addition of Lenalidomide to Patients with Relapsed/Refractory Multiple Myeloma Progressing on Ruxolitinib and Methylprednisolone.
Journal: Targeted oncology
Published: March 04, 2024
Ruxolitinib and methylprednisolone for treatment of patients with relapsed/refractory multiple myeloma.
Journal: British journal of haematology
Published: September 01, 2022
Showing 1-2 of 2
Last Updated: 09/26/2026